OneMedNet Expands Federated Provider Network, Adding Up to 12 Hospitals in iRWD Push

What happened

OneMedNet announced the addition of a leading hospital system to its iRWD platform, with expectations to expand the network by up to 12 hospitals, materially increasing both scale and clinical depth. This move aligns with the company's strategic pivot from BEAM to iRWD and could enhance the attractiveness of its datasets for AI and medtech clients. However, the announcement does not address the company's acute liquidity constraints, with only $0.1 million cash and $1.6 million Bitcoin as of June 30, 2025, and the going-concern flag remains. Revenue remains sub-scale at $155 thousand in Q2 2025, and OneMedNet still faces Nasdaq noncompliance and potential dilution if it utilizes its equity facility. While the network expansion is a positive signal of iRWD traction, it is not yet sufficient to alter the fundamental risk profile.

Implication

Investors should view this announcement as a mildly positive development that could eventually support iRWD revenue growth, but it does not change the near-term financial stress. The company still needs to demonstrate iRWD revenue above $1 million per quarter consecutively and secure adequate funding to avoid dilution. Nasdaq compliance remains a critical risk, and any reverse split could further pressure the stock. Until these issues are resolved, the equity remains high risk with a SELL bias. Watch for follow-through contracts and actual data delivery revenue in upcoming quarters.

Thesis delta

Our SELL stance is unchanged, but the network expansion nudges the thesis slightly less negative if it leads to increased iRWD bookings. The announcement provides a tangible example of strategic validation, one of the watch items, but it is not accompanied by financial impact or new funding. Therefore, while the probability of a positive catalyst has risen, the core risks of liquidity, dilution, and sub-scale revenue remain dominant.